JAMA Dermatology (Archives of dematology)

• 

  Año 2022, Vol. 158, Número 12

  • Apremilast in Recalcitrant Cutaneous DermatomyositisA Nonrandomized Controlled Trial

    Carole Bitar, Thien Ninh, Katherine Brag, Soraya Foutouhi, Stella Radosta, Jade Meyers, Melody Baddoo, Delong Liu, Brittany Stumpf, Paul W. Harms, Nakhle S. Saba, Erin E. Boh

    • Resumen
    • Texto completo

    págs. 1357-1366

    

  • Lifetime Sunburn Trajectories and Associated Risks of Cutaneous Melanoma and Squamous Cell Carcinoma Among a Cohort of Norwegian Women

    Simon Lergenmuller, Corina S. Rueegg, Flavie Perrier, Trude E. Robsahm, Adèle C. Green, Eiliv Lund, Reza Ghiasvand, Marit B. Veierod

    • Resumen
    • Texto completo

    págs. 1367-1377

    

  • Factors Associated With Dermatologic Follow-up vs Emergency Department Return in Patients With Hidradenitis Suppurativa After an Initial Emergency Department Visit

    Cynthia X. Wang, Joanna L Buss, Matthew S. Keller

    • Resumen

    págs. 1378-1386

    

  • Cost-effectiveness of Response-Adapted De-escalation of Immunotherapy in Advanced Melanoma

    Zachary Cartun, Wolfgang G. Kunz, Lucie Heinzerling, Dirk Tomsitz, Anne Guertler, Benedikt Westphalen, Jens Ricke, William Weir, Marcus Unterrainer, Dirk Mehrens

    • Resumen
    • Texto completo

    págs. 1387-1393

    

  • Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial

    Joel M. Gelfand, Daniel B. Shin, April W. Armstrong, Stephen K. Tyring, Andrew Blauvelt, Scott Gottlieb, Benjamin Lockshin, Robert E. Kalb, Robert Fitzsimmons, Justin A. Rodante, Philip Parel, Grigory A. Manyak, Laurel Mendelsohn, Megan H. Noe, Maryte Papadopoulos, Maha N. Syed, Thomas J. Werne, Joy Wan, Martin P. Playford, Abass Alavi, Nehal N. Mehta

    • Resumen
    • Texto completo

    págs. 1394-1403

    

  • Evaluation of Hidradenitis Suppurativa Diagnostic Criteria in Pediatric Patients

    Nicole W. Kittler, Jazzmin C. Williams, Margaret V. Kudlinski, Jenna Lester, Nancy Hills, Katrina Abuabara, Haley B. Naik

    • Resumen
    • Texto completo

    págs. 1404-1408

    

  • Association of Serum Dupilumab Levels at 16 Weeks With Treatment Response and Adverse Effects in Patients With Atopic Dermatitis: A Prospective Clinical Cohort Study From the BioDay Registry

    Lotte S. Spekhorst, Marlies de Graaf, Floris C. Loeff, Nicolaas P.A. Zuithoff, Daphne Bakker, Celeste M. Boesjes, Judith Thijs, Roselie Achten, Femke van Wijk, Theo Rispens, Marjolein De Bruin Weller

    • Resumen
    • Texto completo

    págs. 1409-1413